Nice comment on the petition site @Peter Trewhitt.
Thinking about this, this afternoon, I am wondering why those representatives on the IAG and in the writing team who are there to represent the interests of people with ME/CFS are still sticking with the process.
With NICE, with IQWIG, with CDC, probably with others, a new Cochrane review is redundant. The work has been done and the conclusions are that there is no good evidence to support exercise therapy as a treatment for ME/CFS. A new Cochrane review in, what, two, three, more years? never? is particularly redundant. Simply put, we don't need a new Cochrane review.
What we really need from Cochrane is the removal of the 2019 Larun et al review. And we need that to happen now.
So, how does the ongoing involvement of our representatives in a process that quite possibly will never bear any useful fruit help achieve that review removal in a timely way? Would it not be better for our representatives to give Cochrane an ultimatum - 'remove the flawed harmful review immediately, or the ME/CFS community stops window-dressing this sham process'?
What's the worst that could happen if our representatives withdraw? Cochrane essentially putting an 'approved' stamp on the 2019 review and revealing to the world that they don't understand trial design and review analysis? I don't think everyone in Cochrane wants to do that. But neither do they want to remove that 2019 review, perhaps because people with influence over Cochrane funding don't want it removed. The decision-makers in Cochrane involved seem perfectly happy with kicking the issue down the road for as long as they can get away with doing so. And, at present, we and our representatives inside the process seem to be allowing them to do that.
Of course, I don't know what has been going on, or what pressure has been applied to our representatives. I can only imagine the frustrations of the three years or whatever for those representatives determined to get a good outcome for people with ME/CFS, knowing the harm caused by each month that that 2019 review remains. But, that lack of transparency is a big part of the problem.
I think it is time that our representatives inside the process explained to the ME/CFS community why they continue to stick with it. Do they have a strategy, and is it time to change it?
Thinking about this, this afternoon, I am wondering why those representatives on the IAG and in the writing team who are there to represent the interests of people with ME/CFS are still sticking with the process.
With NICE, with IQWIG, with CDC, probably with others, a new Cochrane review is redundant. The work has been done and the conclusions are that there is no good evidence to support exercise therapy as a treatment for ME/CFS. A new Cochrane review in, what, two, three, more years? never? is particularly redundant. Simply put, we don't need a new Cochrane review.
What we really need from Cochrane is the removal of the 2019 Larun et al review. And we need that to happen now.
So, how does the ongoing involvement of our representatives in a process that quite possibly will never bear any useful fruit help achieve that review removal in a timely way? Would it not be better for our representatives to give Cochrane an ultimatum - 'remove the flawed harmful review immediately, or the ME/CFS community stops window-dressing this sham process'?
What's the worst that could happen if our representatives withdraw? Cochrane essentially putting an 'approved' stamp on the 2019 review and revealing to the world that they don't understand trial design and review analysis? I don't think everyone in Cochrane wants to do that. But neither do they want to remove that 2019 review, perhaps because people with influence over Cochrane funding don't want it removed. The decision-makers in Cochrane involved seem perfectly happy with kicking the issue down the road for as long as they can get away with doing so. And, at present, we and our representatives inside the process seem to be allowing them to do that.
Of course, I don't know what has been going on, or what pressure has been applied to our representatives. I can only imagine the frustrations of the three years or whatever for those representatives determined to get a good outcome for people with ME/CFS, knowing the harm caused by each month that that 2019 review remains. But, that lack of transparency is a big part of the problem.
I think it is time that our representatives inside the process explained to the ME/CFS community why they continue to stick with it. Do they have a strategy, and is it time to change it?
Last edited: